141 related articles for article (PubMed ID: 38296516)
1. Therapeutic role of para-aortic lymphadenectomy in patients with intermediate- and high-risk endometrial cancer: a systematic review and meta-analysis.
Pavone M; Jochum F; Lecointre L; Fanfani F; Scambia G; Querleu D; Akladios C
Int J Gynecol Cancer; 2024 Apr; 34(4):519-527. PubMed ID: 38296516
[TBL] [Abstract][Full Text] [Related]
2. Combined pelvic and para-aortic is superior to only pelvic lymphadenectomy in intermediate and high-risk endometrial cancer: a systematic review and meta-analysis.
Petousis S; Christidis P; Margioula-Siarkou C; Papanikolaou A; Dinas K; Mavromatidis G; Guyon F; Rodolakis A; Vergote I; Kalogiannidis I
Arch Gynecol Obstet; 2020 Jul; 302(1):249-263. PubMed ID: 32468162
[TBL] [Abstract][Full Text] [Related]
3. Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes.
Cuccu I; Raspagliesi F; Malzoni M; Vizza E; Papadia A; Di Donato V; Giannini A; De Iaco P; Perrone AM; Plotti F; Angioli R; Casarin J; Ghezzi F; Cianci S; Vizzielli G; Restaino S; Petrillo M; Sorbi F; Multinu F; Schivardi G; De Vitis LA; Falcone F; Lalli L; Berretta R; Mueller MD; Tozzi R; Chiantera V; Benedetti Panici P; Fanfani F; Scambia G; Bogani G
Eur J Surg Oncol; 2024 Apr; 50(4):108018. PubMed ID: 38428106
[TBL] [Abstract][Full Text] [Related]
4. Lymphadenectomy for the management of endometrial cancer.
Frost JA; Webster KE; Bryant A; Morrison J
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007585. PubMed ID: 28968482
[TBL] [Abstract][Full Text] [Related]
5. Lymphadenectomy for the management of endometrial cancer.
Frost JA; Webster KE; Bryant A; Morrison J
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD007585. PubMed ID: 26387863
[TBL] [Abstract][Full Text] [Related]
6. The risk and pattern of pelvic and para aortic lymph nodal metastasis in patients with intermediate and high risk endometrial cancer.
Rathod PS; Shakuntala PN; Pallavi VR; Kundaragi R; Shankaranand B; Vijay CR; Devi KU; Bafna UD
Indian J Surg Oncol; 2014 Jun; 5(2):109-14. PubMed ID: 25114462
[TBL] [Abstract][Full Text] [Related]
7. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis.
Todo Y; Kato H; Kaneuchi M; Watari H; Takeda M; Sakuragi N
Lancet; 2010 Apr; 375(9721):1165-72. PubMed ID: 20188410
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
9. Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
Bizzarri N; Imterat M; Fruscio R; Giannarelli D; Perrone AM; Mancari R; Traut A; Rosati A; du Bois A; Ferrari D; De Iaco P; Ergasti R; Ataseven B; Bianchi T; Di Stanislao M; Perri MT; Heitz F; Concin N; Fanfani F; Vizza E; Scambia G; Harter P; Fagotti A
Eur J Cancer; 2023 Dec; 195():113398. PubMed ID: 37890354
[TBL] [Abstract][Full Text] [Related]
10. Survival benefits of pelvic lymphadenectomy versus pelvic and para-aortic lymphadenectomy in patients with endometrial cancer: A meta-analysis.
Guo W; Cai J; Li M; Wang H; Shen Y
Medicine (Baltimore); 2018 Jan; 97(1):e9520. PubMed ID: 29505525
[TBL] [Abstract][Full Text] [Related]
11. Does para-aortic lymphadenectomy improve survival in pathologically diagnosed early-stage grade 3 endometrioid and non-endometrioid endometrial cancers? A retrospective cohort study in Korea and Taiwan.
Lai YL; Chang CS; Chang K; Kim HS; Chen J; Cheng WF; Chen YL; Lee YY
Gynecol Oncol; 2022 Oct; 167(1):65-72. PubMed ID: 35995599
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer.
Newton C; Graham R; Liberale V; Burnell M; Menon U; Mould T; Olaitan A; Macdonald N; Widschwendter M; Doufekas K; McCormack M; Mitra A; Arora R; Manchanda R
J Obstet Gynaecol; 2024 Dec; 44(1):2344529. PubMed ID: 38708782
[TBL] [Abstract][Full Text] [Related]
13. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
[TBL] [Abstract][Full Text] [Related]
14. Survival advantage of lymphadenectomy in endometrial cancer.
Eggemann H; Ignatov T; Kaiser K; Burger E; Costa SD; Ignatov A
J Cancer Res Clin Oncol; 2016 May; 142(5):1051-60. PubMed ID: 26746654
[TBL] [Abstract][Full Text] [Related]
15. Lymphadenectomy for the management of endometrial cancer.
May K; Bryant A; Dickinson HO; Kehoe S; Morrison J
Cochrane Database Syst Rev; 2010 Jan; (1):CD007585. PubMed ID: 20091639
[TBL] [Abstract][Full Text] [Related]
16. Association of Pelvic and Para-Aortic Lymphadenectomy With Survival in Stage I Endometrioid Endometrial Cancer: Matched Cohort Analyses From the National Cancer Database.
Seagle BL; Kocherginsky M; Shahabi S
JCO Clin Cancer Inform; 2017 Nov; 1():1-14. PubMed ID: 30657385
[TBL] [Abstract][Full Text] [Related]
17. The role of para-aortic lymphadenectomy in stage IIIC endometrial cancer: A single-institute study.
Kikuchi A; Yanase T; Sasagawa M; Honma S
J Obstet Gynaecol; 2017 May; 37(4):510-513. PubMed ID: 28421906
[TBL] [Abstract][Full Text] [Related]
18. Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6).
Emons G; Kim JW; Weide K; de Gregorio N; Wimberger P; Trillsch F; Gabriel B; Denschlag D; Kommoss S; Aydogdu M; Papathemelis T; Gropp-Meier M; Muallem MZ; Kühn C; Müller A; Frank M; Weigel M; Bronger H; Lampe B; Rau J; Schade-Brittinger C; Harter P
Int J Gynecol Cancer; 2021 Jul; 31(7):1075-1079. PubMed ID: 34226291
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.
Mariani A; Dowdy SC; Cliby WA; Haddock MG; Keeney GL; Lesnick TG; Podratz KC
Gynecol Oncol; 2006 May; 101(2):200-8. PubMed ID: 16510174
[TBL] [Abstract][Full Text] [Related]
20. Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.
Nagar H; Wietek N; Goodall RJ; Hughes W; Schmidt-Hansen M; Morrison J
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013021. PubMed ID: 34106467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
